Biotricity is trading 6.3% down at $0.06; the reason for the decline remains unclear. - No clear company-specific catalyst was identified for October 5, 2026; the company’s news archive lists its latest release as February 11, 2026. - Broader market signals are mixed. Volume was 26.61K versus average daily volume of 87.34K.